PlainRecalls
FDA Drug Moderate Class II Terminated

fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX 77054, NDC 15082-210-72.

Reported: July 4, 2018 Initiated: June 20, 2018 #D-0889-2018

Product Description

fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX 77054, NDC 15082-210-72.

Reason for Recall

Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.

Details

Recalling Firm
Advanced Pharma Inc.
Units Affected
100 syringes
Distribution
Distributed to one medical center in Fort Worth, TX.
Location
Houston, TX

Frequently Asked Questions

What product was recalled?
fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX 77054, NDC 15082-210-72.. Recalled by Advanced Pharma Inc.. Units affected: 100 syringes.
Why was this product recalled?
Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 4, 2018. Severity: Moderate. Recall number: D-0889-2018.